Repository logo
 

TRES predicts transcription control in embryonic stem cells.


Type

Article

Change log

Authors

Pooley, Christopher 
Ruau, David 
Lombard, Patrick 
Joshi, Anagha 

Abstract

SUMMARY: Unraveling transcriptional circuits controlling embryonic stem cell maintenance and fate has great potential for improving our understanding of normal development as well as disease. To facilitate this, we have developed a novel web tool called 'TRES' that predicts the likely upstream regulators for a given gene list. This is achieved by integrating transcription factor (TF) binding events from 187 ChIP-sequencing and ChIP-on-chip datasets in murine and human embryonic stem (ES) cells with over 1000 mammalian TF sequence motifs. Using 114 TF perturbation gene sets, as well as 115 co-expression clusters in ES cells, we validate the utility of this approach. AVAILABILITY AND IMPLEMENTATION: TRES is freely available at http://www.tres.roslin.ed.ac.uk. CONTACT: Anagha.Joshi@roslin.ed.ac.uk or bg200@cam.ac.uk SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Description

Keywords

Animals, Chromatin Immunoprecipitation, Computational Biology, Embryonic Stem Cells, Gene Expression Regulation, Humans, Internet, Mice, Oligonucleotide Array Sequence Analysis, Sequence Analysis, Transcription Factors, Transcription, Genetic

Journal Title

Bioinformatics

Conference Name

Journal ISSN

1367-4803
1367-4811

Volume Title

Publisher

Oxford University Press (OUP)

Rights

DSpace@Cambridge license
Sponsorship
Cancer Research Uk (None)
Biotechnology and Biological Sciences Research Council (BB/I00050X/1)
Leukaemia & Lymphoma Research (12029)
Wellcome Trust (097922/Z/11/Z)
Medical Research Council (MC_PC_12009)
Leukemia & Lymphoma Society (7001-12)
National Centre for the Replacement Refinement and Reduction of Animals in Research (G0900729/1)
This work was supported by a University of Edinburgh Chancellors Fellowship awarded to AJ and strategic funding from the BBSRC. CP was funded by the Scottish Government through the Strategic Partnership for Animal Science Excellence (SPASE). The Gottgens’ lab is supported by LLR, the MRC, BBSRC, Cancer Research UK, and Wellcome Trust core support to the Cambridge Institute for Medical Research and Wellcome Trust–MRC Cambridge Stem Cell Institute.